Skip to search formSkip to main contentSkip to account menu

Cetuximab-IRDye 800CW

Known as: Cetuximab-IRDye 800, Cetuximab-IRDye800, Cetuximab-IRDye800CW 
An immunoconjugate comprised of the recombinant chimeric monoclonal antibody cetuximab conjugated to the N-hydroxysuccinamide (NHS) ester form of the… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
PurposeABY-029, a synthetic Affibody peptide, Z03115-Cys, labeled with a near-infrared fluorophore, IRDye® 800CW, targeting… 
Highly Cited
2017
Highly Cited
2017
BackgroundPretargeting-based approaches are being investigated for radioimmunoimaging and therapy applications to reduce the… 
2017
2017
Gastrin-releasing peptide (GRP) receptors (GRPr) are frequently overexpressed in human prostate cancer, and radiolabeled GRPr… 
2013
2013
Combined treatment of advanced head and neck squamous cell carcinomas (HNSCC) with radiotherapy and the epidermal growth factor… 
Highly Cited
2012
Highly Cited
2012
Liposomes are effective lipid nanoparticle drug delivery systems, which can also be functionalized with noninvasive multimodality… 
Review
2012
Review
2012
Glucose homeostasis is a fundamental aspect of life and its dysregulation is associated with important diseases, such as cancer… 
Highly Cited
2010
Highly Cited
2010
ObjectiveFluorophore-labeled contrast imaging agents are moving toward clinical use for a number of applications. The near… 
Highly Cited
2007
Highly Cited
2007
Molecular imaging of cell surface receptors can potentially diagnose tumors based on their distinct expression profiles. Using…